Suppr超能文献

高通量测序揭示非酒精性脂肪性肝病相关纤维化中肝脏微小RNA的表达改变。

High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.

作者信息

Leti Fatjon, Malenica Ivana, Doshi Meera, Courtright Amanda, Van Keuren-Jensen Kendall, Legendre Christophe, Still Christopher D, Gerhard Glenn S, DiStefano Johanna K

机构信息

Division of Diabetes, Cardiovascular and Metabolic Diseases, Translational Genomics Research Institute, Phoenix, Ariz.

Department of Gastroenterology and Nutrition, Geisinger Obesity Institute, Danville, PA.

出版信息

Transl Res. 2015 Sep;166(3):304-14. doi: 10.1016/j.trsl.2015.04.014. Epub 2015 May 4.

Abstract

Recent evidence suggests that microRNAs (miRNAs), small, noncoding RNA molecules that regulate gene expression, may play a role in the regulation of metabolic disorders, including nonalcoholic fatty liver disease (NAFLD). To identify miRNAs that mediate NAFLD-related fibrosis, we used high-throughput sequencing to assess miRNAs obtained from liver biopsies of 15 individuals without NAFLD fibrosis (F0) and 15 individuals with severe NAFLD fibrosis or cirrhosis (F3-F4), matched for age, sex, body mass index, type 2 diabetes status, hemoglobin A1c, and use of diabetes medications. We used DESeq2 and Kruskal-Wallis test to identify miRNAs that were differentially expressed between NAFLD patients with or without fibrosis, adjusting for multiple testing using Bonferroni correction. We identified a total of 75 miRNAs showing statistically significant evidence (adjusted P value <0.05) for differential expression between the 2 groups, including 30 upregulated and 45 downregulated miRNAs. Quantitative reverse-transcription polymerase chain reaction analysis of selected miRNAs identified by sequencing validated 9 of 11 of the top differentially expressed miRNAs. We performed functional enrichment analysis of dysregulated miRNAs and identified several potential gene targets related to NAFLD-related fibrosis including hepatic fibrosis, hepatic stellate cell activation, transforming growth factor beta signaling, and apoptosis signaling. We identified forkhead box O3 and F-box WD repeat domain containing 7, E3 ubiquitin protein ligase (FBXW7) as potential targets of miR-182, and found that levels of forkhead box O3, but not FBXW7, were significantly decreased in fibrotic samples. These findings support a role for hepatic miRNAs in the pathogenesis of NAFLD-related fibrosis and yield possible new insight into the molecular mechanisms underlying the initiation and progression of liver fibrosis and cirrhosis.

摘要

近期证据表明,微小RNA(miRNA),即调节基因表达的小型非编码RNA分子,可能在包括非酒精性脂肪性肝病(NAFLD)在内的代谢紊乱调节中发挥作用。为了鉴定介导NAFLD相关纤维化的miRNA,我们使用高通量测序来评估从15名无NAFLD纤维化(F0)个体和15名患有严重NAFLD纤维化或肝硬化(F3 - F4)个体的肝活检中获得的miRNA,这些个体在年龄、性别、体重指数、2型糖尿病状态、糖化血红蛋白以及糖尿病药物使用方面相匹配。我们使用DESeq2和Kruskal - Wallis检验来鉴定在有或无纤维化的NAFLD患者之间差异表达的miRNA,并使用Bonferroni校正对多重检验进行调整。我们总共鉴定出75个miRNA在两组之间差异表达具有统计学显著证据(校正P值<0.05),包括30个上调的和45个下调的miRNA。对通过测序鉴定的选定miRNA进行定量逆转录聚合酶链反应分析,验证了11个差异表达最显著的miRNA中的9个。我们对失调的miRNA进行了功能富集分析,并鉴定出几个与NAFLD相关纤维化相关的潜在基因靶点,包括肝纤维化、肝星状细胞活化、转化生长因子β信号传导和凋亡信号传导。我们鉴定出叉头框O3和含F - 盒WD重复结构域7的E3泛素蛋白连接酶(FBXW7)作为miR - 182的潜在靶点,并发现纤维化样本中叉头框O3的水平显著降低,但FBXW7的水平未降低。这些发现支持肝脏miRNA在NAFLD相关纤维化发病机制中的作用,并为肝纤维化和肝硬化发生及进展的分子机制提供了可能的新见解。

相似文献

1
4
Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
Transl Res. 2017 Feb;180:103-117.e4. doi: 10.1016/j.trsl.2016.08.006. Epub 2016 Aug 31.
5
A micro-RNA expression signature for human NAFLD progression.
J Gastroenterol. 2016 Oct;51(10):1022-30. doi: 10.1007/s00535-016-1178-0. Epub 2016 Feb 13.
6
Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
Nutr Metab Cardiovasc Dis. 2016 Dec;26(12):1129-1139. doi: 10.1016/j.numecd.2016.08.004. Epub 2016 Aug 20.
8
Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH.
Biomark Med. 2015;9(11):1189-200. doi: 10.2217/bmm.15.70. Epub 2015 Oct 28.

引用本文的文献

1
4
Predictive value of miR-582-5p for onset of sepsis-induced acute kidney injury and its functional role during disease development.
Cent Eur J Immunol. 2024;49(4):383-392. doi: 10.5114/ceji.2024.145730. Epub 2024 Dec 11.
6
Integrating Genetic and Transcriptomic Data to Identify Genes Underlying Obesity Risk Loci.
medRxiv. 2024 Jun 12:2024.06.11.24308730. doi: 10.1101/2024.06.11.24308730.
10
The Role of CYP3A in Health and Disease.
Biomedicines. 2022 Oct 24;10(11):2686. doi: 10.3390/biomedicines10112686.

本文引用的文献

1
Genome-wide analysis of hepatic lipid content in extreme obesity.
Acta Diabetol. 2015 Apr;52(2):373-82. doi: 10.1007/s00592-014-0654-3. Epub 2014 Sep 23.
3
miR-182 attenuates atrophy-related gene expression by targeting FoxO3 in skeletal muscle.
Am J Physiol Cell Physiol. 2014 Aug 15;307(4):C314-9. doi: 10.1152/ajpcell.00395.2013. Epub 2014 May 28.
4
Saturated free fatty acids induce cholangiocyte lipoapoptosis.
Hepatology. 2014 Dec;60(6):1942-56. doi: 10.1002/hep.27175. Epub 2014 Jun 20.
5
MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma.
Chin J Cancer Res. 2014 Feb;26(1):17-29. doi: 10.3978/j.issn.1000-9604.2014.01.01.
6
Sp1-mediated microRNA-182 expression regulates lung cancer progression.
Oncotarget. 2014 Feb 15;5(3):740-53. doi: 10.18632/oncotarget.1608.
8
Deep sequencing of small RNA repertoires in mice reveals metabolic disorders-associated hepatic miRNAs.
PLoS One. 2013 Nov 15;8(11):e80774. doi: 10.1371/journal.pone.0080774. eCollection 2013.
9
Hepatitis C and alcohol exacerbate liver injury by suppression of FOXO3.
Am J Pathol. 2013 Dec;183(6):1803-1814. doi: 10.1016/j.ajpath.2013.08.013. Epub 2013 Nov 11.
10
Critical role of FoxO3a in alcohol-induced autophagy and hepatotoxicity.
Am J Pathol. 2013 Dec;183(6):1815-1825. doi: 10.1016/j.ajpath.2013.08.011. Epub 2013 Oct 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验